TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11191092

Group type: COMPARATOR
Intervention: Desogestrel (150 microg orally daily) and testosterone pellets (2 x 200 mg per 12 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Desogestrel (150 microg orally daily) and testosterone pellets (2 x 200 mg per 12 weeks) with finasteride (5 mg orally daily)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (control and FIN)
Number of subjects: 16
Study: 9682338

Group type: EXPERIMENTAL
Intervention: DTP/PRP-T combined in a dual-chamber syringe (D-Ch group, n = 239)
Number of subjects: 537

Group type: COMPARATOR
Intervention: DTP@PRP-T combined in a single-chamber syringe (C-In group, n = 61)
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: DTP + PRP-T administered in separate injections (S-In group, n = 237)
Number of subjects: 537
Study: 7982415

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulphate (46-52 mmol/18-20 h)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Oral magnesium hydroxide (600 mg/day)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control group (no magnesium treatment)
Number of subjects: 148
Study: 3422667

Group type: COMPARATOR
Intervention: Mixed-fluoride dentifrice (1,000 ppm F)
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Mixed-fluoride dentifrice (2,500 ppm F)
Number of subjects: 2509

Group type: EXPERIMENTAL
Intervention: Conventional Na2PO3F dentifrice (1,000 ppm F)
Number of subjects: 2509
Study: 29478953

Group type: EXPERIMENTAL
Intervention: Cartoons with healthy eating messages
Number of subjects: 142

Group type: COMPARATOR
Intervention: Cartoons with no reference to food (comparison group)
Number of subjects: 142
Study: 26457893

Group type: EXPERIMENTAL
Intervention: Interactive group music therapy (n = 62; 20 units of 40 minutes, 2×/week)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Recreational group singing (n = 55; 10 units of 90 minutes, 1×/week)
Number of subjects: 117
Study: 26077620

Group type: EXPERIMENTAL
Intervention: Telephone Cognitive Behavioral Therapy (T‐CBT)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Face-to-Face Cognitive Behavioral Therapy (FtF‐CBT)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Coping self-efficacy (CSE) scale
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Low CSE
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Social support, physical functioning, and employment
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Sex
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Treatment delivery method (T‐CBT vs FtF‐CBT)
Number of subjects: 325
Study: 22795245

Group type: EXPERIMENTAL
Intervention: Admission hyperglycemia (highest glucose tertile)
Number of subjects: 3405

Group type: EXPERIMENTAL
Intervention: Admission hyperglycemia (highest glucose tertile) in patients with diabetes
Number of subjects: 3405

Group type: EXPERIMENTAL
Intervention: Admission hyperglycemia (highest glucose tertile) in patients without diabetes
Number of subjects: 3405

Group type: EXPERIMENTAL
Intervention: Baseline hyperglycemia
Number of subjects: 3405

Group type: EXPERIMENTAL
Intervention: Baseline hyperglycemia in patients with diabetes
Number of subjects: 3405

Group type: EXPERIMENTAL
Intervention: Baseline hyperglycemia in patients without diabetes
Number of subjects: 3405
Study: 21709518

Group type: EXPERIMENTAL
Intervention: Social support intervention (home visits and phone calls) for fathers (n = 19)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (phone number of an experienced parent to call as needed) for fathers (n = 9)
Number of subjects: 28
Study: 18353632

Group type: EXPERIMENTAL
Intervention: Recent treatment protocols with higher cumulative doses or increased dose intensity of alkylators and epipodophyllotoxins and the use of G-CSF
Number of subjects: 237

Group type: COMPARATOR
Intervention: Earlier treatment protocols
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Overall treatment for ESFT
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Secondary leukaemia (SL)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Secondary solid tumours
Number of subjects: 237
Study: 16850908

Group type: EXPERIMENTAL
Intervention: Carbamazepine + Melatonin (CBZ+MEL)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Valproate + Melatonin (VPA+MEL)
Number of subjects: 22
Study: 12620695

Group type: EXPERIMENTAL
Intervention: Prior antihypertensive treatment
Number of subjects: 960
Study: 11137246

Group type: EXPERIMENTAL
Intervention: High-dose hepatitis A and B vaccine (2 doses at month 0 and 6)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Twinrix (3 doses at month 0, 1, and 6)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: High-dose hepatitis A and B vaccine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Twinrix
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 100
Study: 9196432

Group type: EXPERIMENTAL
Intervention: PRINS technique for detecting chromosome gains or losses in interphase nuclei
Number of subjects: 10

Group type: COMPARATOR
Intervention: FISH analysis
Number of subjects: 10
Study: 8482290

Group type: EXPERIMENTAL
Intervention: Long prednisone therapy (60 mg/m2 per 24 h for 6 weeks, followed by alternate day 40 mg/m2 per 48 h for 6 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard prednisone therapy (60 mg/m2 per 24 h for 4 weeks, followed by 40 mg/m2 per 48 h for 4 weeks)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Long prednisone therapy
Number of subjects: 71

Group type: COMPARATOR
Intervention: Standard prednisone therapy
Number of subjects: 71
Study: 3434601

Group type: EXPERIMENTAL
Intervention: Models administration of three-dimensional constructional praxis tests
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Photographs administration of three-dimensional constructional praxis tests
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Drawings administration of three-dimensional constructional praxis tests
Number of subjects: 24
Study: 29306481

Group type: EXPERIMENTAL
Intervention: Standard treatment + 25(OH)D3 supplementation
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with 25(OH)D levels ≤ 50 nmol/L
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Patients with 25(OH)D levels > 50 nmol/L
Number of subjects: 41
Study: 26685099

Group type: EXPERIMENTAL
Intervention: Oral sucrose combined with NNS (group NS)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Oral sucrose combined with swaddling (group SS)
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: Oral sucrose combined with NNS and swaddling (group NSS)
Number of subjects: 671

Group type: COMPARATOR
Intervention: Oral sucrose (routine care, group S)
Number of subjects: 671
Study: 25639787

Group type: EXPERIMENTAL
Intervention: Left-Colon Water Exchange (LWE)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Whole-Colon Water Exchange (WWE)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Air Insufflation (AI)
Number of subjects: 300
Study: 23733781

Group type: EXPERIMENTAL
Intervention: Multiparameter flow cytometry (MFC) assessment of minimal residual disease (MRD) after ASCT
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Maintenance thalidomide
Number of subjects: 378

Group type: COMPARATOR
Intervention: MRD assessment after induction therapy in non-intensive-pathway patients
Number of subjects: 378
Study: 20956707

Group type: EXPERIMENTAL
Intervention: Reciprocal peer support (RPS)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Nurse care management (NCM)
Number of subjects: 244
Study: 18350366

Group type: EXPERIMENTAL
Intervention: Information booklets provided to participants within 72 hours of the initial trauma.
Number of subjects: 103

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 103
Study: 19641202

Group type: EXPERIMENTAL
Intervention: Oral artesunate at a dose of 2 mg/kg/day for 7 days
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Artesunate at a dose of 4 mg/kg/day for 3 days followed by mefloquine at a total dose of 25 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Artesunate monotherapy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Artesunate-mefloquine therapy
Number of subjects: 80
Study: 15774110

Group type: EXPERIMENTAL
Intervention: Burst mode phaco power
Number of subjects: 178

Group type: COMPARATOR
Intervention: Pulse mode phaco power
Number of subjects: 178

Group type: COMPARATOR
Intervention: Continuous mode phaco power
Number of subjects: 178
Study: 11167792

Group type: EXPERIMENTAL
Intervention: TAD-HAM (high-dose AraC, mitoxantrone)
Number of subjects: 90

Group type: COMPARATOR
Intervention: TAD-TAD (thioguanine, daunorubicin, cytosine arabinoside)
Number of subjects: 90
Study: 9720995

Group type: EXPERIMENTAL
Intervention: Intermittent exposure to hypoxia during exercise training (30 min x day(‐1) for 6 days)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (inactive)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intermittent exposure to hypoxia (with or without exercise training)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Training group (intermittent exposure to hypoxia)
Number of subjects: 13
Study: 8152203

Group type: EXPERIMENTAL
Intervention: Cefixime 8 mg/kg bodyweight once daily
Number of subjects: 154

Group type: COMPARATOR
Intervention: Penicillin V 20,000 I.E. /kg bodyweight t.i.d.
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 154

Group type: COMPARATOR
Intervention: Penicillin V
Number of subjects: 154
Study: 3048643

Group type: COMPARATOR
Intervention: DDP (100 mg/m2; day 1)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DDP + 5-fluorouracil (1 g/m2 continuous infusion for 5 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: DDP
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: DDP + 5-fluorouracil
Number of subjects: 74
Study: 31991298

Group type: EXPERIMENTAL
Intervention: Low glycemic index/high fat, high-calorie diet
Number of subjects: 44

Group type: COMPARATOR
Intervention: High fat, high-calorie diet
Number of subjects: 44
Study: 31325348

Group type: EXPERIMENTAL
Intervention: Health education by telephone follow-up (4 times after discharge)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (telephone follow-up once after discharge)
Number of subjects: 92
Study: 28486643

Group type: EXPERIMENTAL
Intervention: Worksite self-management (WSM)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Intensive health monitoring (IM)
Number of subjects: 180
Study: 26385357

Group type: EXPERIMENTAL
Intervention: Pilates exercise (60-minute class, twice weekly for 12 weeks)
Number of subjects: 53
Study: 24373475

Group type: EXPERIMENTAL
Intervention: Novel flight planning optimization application
Number of subjects: 839

Group type: COMPARATOR
Intervention: Traditional planning methods (manual methods)
Number of subjects: 839
Study: 23046006

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (CP) mouth rinse, rinsed four times a day
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (CP) mouth rinse
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (not using CP mouth rinse)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Historical control group (not using CP mouth rinse)
Number of subjects: 52
Study: 19412946

Group type: EXPERIMENTAL
Intervention: CLE (37.7, 150, 200 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: CL-CR (50 and 200 mg)
Number of subjects: 17
Study: 17460371

Group type: EXPERIMENTAL
Intervention: telmisartan 80 mg/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: losartan 50 mg/day
Number of subjects: 42
Study: 15563049

Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 75

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 75

Group type: COMPARATOR
Intervention: Psychiatric patients
Number of subjects: 75
Study: 11352208

Group type: EXPERIMENTAL
Intervention: Awareness of base-rate changes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Working memory capacity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulated working memory load
Number of subjects: 0
Study: 9626231

Group type: EXPERIMENTAL
Intervention: Mitoxantrone plus prednisone (M + P)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Prednisone alone (P)
Number of subjects: 161
Study: 7887099

Group type: EXPERIMENTAL
Intervention: Isoflurane (n = 20)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Halothane (n = 19)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Fentanyl (n = 17)
Number of subjects: 56
Study: 3269553

Group type: EXPERIMENTAL
Intervention: Psychodynamic conflict-centered therapy (n = 34)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Client-centered therapy (n = 34)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Nontreated control group (n = 19)
Number of subjects: 87
Study: 29623516

Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) treatment (0.5-3.0 g/(kg·d))
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo (non-L-T4 treatment)
Number of subjects: 64
Study: 27194097

Group type: EXPERIMENTAL
Intervention: Physician-pharmacist collaborative care
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 56
Study: 25001365

Group type: EXPERIMENTAL
Intervention: High neck circumference (NC)
Number of subjects: 2318

Group type: EXPERIMENTAL
Intervention: High neck circumference (NC) among hypertensive individuals
Number of subjects: 2318

Group type: EXPERIMENTAL
Intervention: High neck circumference (NC) among non-hypertensive individuals
Number of subjects: 2318
Study: 22275738

Group type: EXPERIMENTAL
Intervention: CartoSound module with SoundStar ICE catheter for pulmonary vein isolation
Number of subjects: 8
Study: 20699743

Group type: EXPERIMENTAL
Intervention: Recombinant activated factor VII
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18268081

Group type: COMPARATOR
Intervention: OPT-80 (100, 200, 300, and 450 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: OPT-80 (150, 300, or 450 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15707996

Group type: EXPERIMENTAL
Intervention: G11778A mutation in ND4 gene
Number of subjects: 38

Group type: COMPARATOR
Intervention: Mitochondrial genome analysis
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Incomplete penetrance of LHON
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Other mtDNA variants
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Nuclear modifier gene(s) or environmental factor(s)
Number of subjects: 38
Study: 15259402

Group type: EXPERIMENTAL
Intervention: Dementia with Lewy bodies (DLB)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 59
Study: 10467831

Group type: EXPERIMENTAL
Intervention: Fortnightly education talk on hand‐washing and skin hygiene (Group 1, n = 70)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Fortnightly education talk on family planning (Group 2, n = 84)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Health education programme (1981-1994)
Number of subjects: 154
Study: 8543232

Group type: EXPERIMENTAL
Intervention: Dead Sea bath salts (Group I)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sodium chloride (Group II)
Number of subjects: 26
Study: 2794095

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 0
Study: 797427

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (4,000 rads in 4 weeks) plus radical cystectomy
Number of subjects: 189

Group type: COMPARATOR
Intervention: Radical irradiation (6,000 rads in 6 weeks)
Number of subjects: 189
Study: 29866386

Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV) for smoking abstinence (twice‐daily carbon monoxide [CO] readings)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Contingent vouchers (CV) for smoking abstinence
Number of subjects: 184

Group type: COMPARATOR
Intervention: Non-contingent vouchers (NV) plus counseling to motivate smoking cessation
Number of subjects: 184
Study: 27181260

Group type: EXPERIMENTAL
Intervention: Nerve Growth Factor (NGF) with corticosteroids, injected intramuscularly at 18μg once a day for 2 months.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Corticosteroids with gradually reduced dosage (control group).
Number of subjects: 28
Study: 25043685

Group type: EXPERIMENTAL
Intervention: Intensive treatment during DCCT
Number of subjects: 1441

Group type: COMPARATOR
Intervention: Conventional treatment during DCCT
Number of subjects: 1441
Study: 22897408

Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal by mouth every 4 hours
Number of subjects: 17

Group type: COMPARATOR
Intervention: No activated charcoal (control)
Number of subjects: 17
Study: 21280423

Group type: EXPERIMENTAL
Intervention: Experimental stannous-containing dentifrice
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Colgate Total (non-staining marketed triclosan dentifrice)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Crest Gum Care (0.454% stannous fluoride dentifrice)
Number of subjects: 96
Study: 18425074

Group type: EXPERIMENTAL
Intervention: White mineral trioxide aggregate (MTA)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Formocresol (FC)
Number of subjects: 46
Study: 15973546

Group type: EXPERIMENTAL
Intervention: Increased central pressure augmentation (AG)
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Aortic systolic blood pressure
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Diabetes duration
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Increased AG (adjusted for sex, age and heart rate)
Number of subjects: 228
Study: 14507948

Group type: EXPERIMENTAL
Intervention: D-dimer testing followed by ultrasound imaging unless D-dimer test was negative and clinically unlikely for DVT
Number of subjects: 1096

Group type: COMPARATOR
Intervention: Ultrasound imaging alone (control group)
Number of subjects: 1096

Group type: EXPERIMENTAL
Intervention: D-dimer testing
Number of subjects: 1096
Study: 10650901

Group type: EXPERIMENTAL
Intervention: High-dose loperamide (initial dose of 4 mg followed by 4 mg every 8 h, total dose 16 mg/24 h)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: High-dose loperamide
Number of subjects: 37
Study: 9192198

Group type: EXPERIMENTAL
Intervention: High sodium diet (300 mmol/d)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Low sodium diet (50 mmol/d)
Number of subjects: 22
Study: 8458449

Group type: EXPERIMENTAL
Intervention: GnRH-a (buserelin acetate, goserelin, nafarelin acetate)
Number of subjects: 130
Study: 3947491

Group type: EXPERIMENTAL
Intervention: Lumbar extradural analgesia with 0.5% bupivacaine (Group I)
Number of subjects: 20

Group type: COMPARATOR
Intervention: General anaesthesia with spontaneous respiration, using 60% nitrous oxide and 1‐2% halothane in oxygen (Group II)
Number of subjects: 20
Study: 31278755

Group type: EXPERIMENTAL
Intervention: Low pH (4.0)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal pH (6.0)
Number of subjects: 0
Study: 29604181

Group type: EXPERIMENTAL
Intervention: Default online shopping cart containing a nutritionally balanced selection of groceries (n=18)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Education about nutrition (n=24)
Number of subjects: 59

Group type: COMPARATOR
Intervention: $10 incentive for selecting nutritious groceries (n=17)
Number of subjects: 59
Study: 27835977

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) training
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional Training (CT)
Number of subjects: 50
Study: 24977755

Group type: EXPERIMENTAL
Intervention: Propranolol (BB)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (no BB)
Number of subjects: 45
Study: 22367416

Group type: EXPERIMENTAL
Intervention: Training group (n=8) - 10-week hip strengthening programme, twice weekly
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (n=8) - usual activities
Number of subjects: 16
Study: 20152960

Group type: EXPERIMENTAL
Intervention: Guided self-help
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: E-mail therapy
Number of subjects: 88

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 88
Study: 18582372

Group type: EXPERIMENTAL
Intervention: Salpingostomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Salpingectomy
Number of subjects: 100
Study: 15786902

Group type: EXPERIMENTAL
Intervention: Oral insertion
Number of subjects: 307
Study: 11265923

Group type: EXPERIMENTAL
Intervention: Combination treatment (Comb)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Medication management (MedMgt)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Behavioral treatment (Beh)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Routine community care (CC)
Number of subjects: 579

Group type: COMPARATOR
Intervention: Intensive behavioral treatment (Beh)
Number of subjects: 579
Study: 9505740

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.02, 0.025, or 0.03 mg kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Atracurium (0.075, 0.01, or 0.0125 mg.kg‐1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of 1 x ED95 of vecuronium + 1 x ED95 of atracurium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (2 x ED95 of vecuronium or atracurium)
Number of subjects: 60
Study: 7849235

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1500 mg IV
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefuroxime 1000 mg IV
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flucloxacillin 2000 mg IV
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flucloxacillin 1500 mg IV
Number of subjects: 30

Group type: COMPARATOR
Intervention: Flucloxacillin 1000 mg IV
Number of subjects: 30
Study: 3404136

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Simulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Neutral Control
Number of subjects: 30
Study: 1437767

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (Zincteral) 200 mg 4 times daily for 12 months
Number of subjects: 9

Group type: COMPARATOR
Intervention: D-penicillamine (Cuprenil-Polfa) 1.0-1.5 g daily
Number of subjects: 9
Study: 360760

Group type: EXPERIMENTAL
Intervention: Ro 8-4650
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31598823

Group type: EXPERIMENTAL
Intervention: Intravenous phenylephrine (PE) bolus of 1 µg kg−1
Number of subjects: 28